Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population

PURPOSE: Single-agent EGFR inhibitor therapy is effective mainly in patients with lung cancer and EGFR mutations. Treating patients who develop resistance, or who are insensitive from the outset, often because of resistant mutations, other aberrations or the lack of an EGFR mutation, probably requir...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Wheler, Jennifer, Falchook, Gerald, Tsimberidou, Apostolia M., Hong, David, Naing, Aung, Piha-Paul, Sarina, Chen, Su S., Heymach, John, Fu, Siqing, Stephen, Bettzy, Fok, Jansina Y., Janku, Filip, Kurzrock, Razelle
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2013
Onderwerpen:
Research Papers
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742837/
https://ncbi.nlm.nih.gov/pubmed/23800712
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items